rf-fullcolor.png

 

November 18, 2014
by Stewart Eisenhart

ANVISA to Allow Medical Device Firms to Evaluate Their Inspections

Content provided by Emergo Group, a medical device regulatory affairs and quality assurance consulting firm with offices worldwide.

Brazilian medical device regulator ANVISA has begun accepting feedback from medical device companies subject to quality management inspections in order to improve and standardize inspection processes.

Firms inspected for Brazilian Good Manufacturing Practice (BGMP) compliance now have the option of submitting a form to ANVISA providing their perspective on how their quality system inspections went, and what could be improved.

For the time being, the evaluation program is meant only for investigational purposes, but does perhaps show willingness by Brazilian regulators to take more industry feedback into consideration during the BGMP inspection process over the longer term. 

Learn more about Brazilian registration and BGMP compliance here.

 

Original Post: Emergo Group

Related Post: Brazil relaxes BGMP requirements for manufacturers holding INMETRO certification

Related Post: New Regulation in Brazil Changes Enforcement of BGMP Requirements for Certain Medical Devices

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.